相似文献
1
Pentamidine Congeners 1: Synthesis of Cis- and Trans-Butamidine Analogues As Anti-Pneumocystis carinii Pneumonia Agents.
Bioorg Med Chem Lett. 1993;3(6):1137-1140. doi: 10.1016/S0960-894X(00)80302-9.
2
Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine.
Mol Pharmacol. 1994 Aug;46(2):313-22.
3
Pentamidine congeners. 2. 2-butene-bridged aromatic diamidines and diimidazolines as potential anti-Pneumocystis carinii pneumonia agents.
J Med Chem. 1994 Dec 23;37(26):4554-7. doi: 10.1021/jm00052a014.
4
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.
J Med Chem. 1990 Apr;33(4):1252-7. doi: 10.1021/jm00166a026.
5
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1990 Jun;34(6):1026-30. doi: 10.1128/AAC.34.6.1026.
6
[Pneumocystis carinii infection during prophylaxis with nebulized pentamidine in a patient with AIDS].
Ned Tijdschr Geneeskd. 1991 Mar 9;135(10):424-7.
7
Increased Pneumocystis carinii recovery from the upper lobes in Pneumocystis pneumonia. The effect of aerosol pentamidine prophylaxis.
Chest. 1993 Feb;103(2):426-32. doi: 10.1378/chest.103.2.426.
8
Pentamidine congeners. 3. Crystal structure and molecular modeling studies of trans-1,4-bis(4-amidinophenoxy)-2-butene.
J Pharm Sci. 1995 Apr;84(4):448-55. doi: 10.1002/jps.2600840412.
9
[Randomized comparative study of secondary prevention of Pneumocystis carinii pneumonia in patients with acquired immunologic deficiency syndrome].
Med Klin (Munich). 1990 Apr;85 Suppl 2:281-5.
本文引用的文献
1
Assessment of therapy for pneumocystis carinii pneumonia. PCP Therapy Project Group.
Am J Med. 1984 Mar;76(3):501-8. doi: 10.1016/0002-9343(84)90670-3.
2
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.
Ann Intern Med. 1984 Apr;100(4):495-9. doi: 10.7326/0003-4819-100-4-495.
3
The effects of antimicrobial agents on ribonucleic acid polymerase.
Mol Pharmacol. 1965 Jul;1(1):1-13.
4
Latent Pneumocystis infection of rats, relapse, and chemotherapy.
Lab Invest. 1966 Oct;15(10):1559-77.
5
Diamidino-alpha,omega-diphenoxyalkanes. Structure-activity relationships for the inhibition of thrombin, pancreatic kallikrein, and trypsin.
J Med Chem. 1973 Sep;16(9):970-5. doi: 10.1021/jm00267a003.
6
Update: acquired immunodeficiency syndrome--United States.
MMWR Morb Mortal Wkly Rep. 1985 May 10;34(18):245-8.
7
Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1988 Jun;32(6):896-905. doi: 10.1128/AAC.32.6.896.
8
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.
J Med Chem. 1990 Apr;33(4):1252-7. doi: 10.1021/jm00166a026.
9
Polyamine metabolism in Pneumocystis carinii.
J Infect Dis. 1991 May;163(5):1121-7. doi: 10.1093/infdis/163.5.1121.
10
New aromatic diamidines with central alpha-oxyalkane or alpha, omega-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation process.
J Med Chem. 1975 May;18(5):477-81. doi: 10.1021/jm00239a007.
Zotero 插件